Balancing the risks and benefits of parenteral nutrition for preterm infants: can we define the optimal composition?

Area of Science:

• Neonatal Medicine
• Nutritional Science
• Developmental Pediatrics

Background:

• Nutrient intake is often insufficient in preterm infants, negatively affecting neurodevelopmental outcomes.
• Parenteral nutrition (PN) is essential for preterm infants but lacks robust evidence regarding optimal composition.
• Current research on PN for neonates primarily focuses on short-term growth, with limited long-term follow-up data.

Purpose of the Study:

• To highlight the critical need for evidence-based guidelines on parenteral nutrition (PN) for preterm infants.
• To emphasize the uncertainty surrounding safe and effective macronutrient, amino acid, and lipid intakes in neonatal PN.
• To advocate for research prioritizing long-term neurodevelopmental and metabolic outcomes in preterm infants receiving PN.

Main Methods:

• Review of existing literature on parenteral nutrition in preterm infants.
• Analysis of current evidence gaps concerning macronutrient and micronutrient composition.
• Identification of the need for long-term follow-up studies to assess cognitive and metabolic outcomes.

Main Results:

• Evidence supporting optimal PN intakes in preterm infants is severely limited.
• Uncertainty persists regarding safe initial/maximum macronutrient amounts and optimal nutrient composition.
• Existing studies predominantly assess short-term growth, neglecting long-term health implications.

Conclusions:

• Optimizing PN composition is a research priority in neonatal medicine due to its impact on long-term health.
• Balancing cognitive benefits with metabolic harm necessitates long-term studies for PN regimen determination.
• Improved PN strategies are vital for enhancing preterm infant metabolic and cognitive health, potentially reducing healthcare costs.